Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	1,105	1,274	1,506	193.46
Trading Asset Securities	-	75.52	0.12	3.97	-
Cash & Short-Term Investments	1,149	1,181	1,274	1,510	193.46
Cash Growth	-2.68%	-7.33%	-15.61%	680.49%	43.70%
Accounts Receivable	-	227.37	237.35	177.37	124.68
Other Receivables	-	15.39	10.66	16.79	9.89
Receivables	-	242.76	248.01	194.16	134.57
Inventory	-	760.22	699.43	521.86	476.55
Prepaid Expenses	-	4.19	5.61	2.47	0.04
Other Current Assets	-	20.7	33.92	16.19	13.1
Total Current Assets	-	2,209	2,261	2,245	817.71
Property, Plant & Equipment	-	166.88	97.32	75.45	60.04
Other Intangible Assets	-	3.95	0.6	0.21	0.44
Long-Term Deferred Tax Assets	-	14.74	18.36	3.88	2.97
Long-Term Deferred Charges	-	23.74	37.58	16.81	22.13
Other Long-Term Assets	-	-	-	18.25	2.84
Total Assets	-	2,418	2,415	2,359	906.13
Accounts Payable	-	216.32	179.57	167.37	206.07
Accrued Expenses	-	31.38	36.26	30.1	18.57
Short-Term Debt	-	30.18	0.23	9.61	0.07
Current Portion of Leases	-	14.06	15.88	-	-
Current Income Taxes Payable	-	12.85	6.49	6.22	8.39
Current Unearned Revenue	-	36.69	29.07	20.52	14.68
Other Current Liabilities	-	4.28	7.47	15.25	1.78
Total Current Liabilities	-	345.76	274.97	249.07	249.56
Long-Term Leases	-	37.95	41.19	31.21	27.71
Long-Term Deferred Tax Liabilities	-	7.2	8.06	2.77	-
Other Long-Term Liabilities	-	-	1.27	-	-
Total Liabilities	-	390.91	325.49	283.05	277.27
Common Stock	-	90.88	90.88	64.92	48.69
Additional Paid-In Capital	-	1,755	1,754	1,776	483.24
Retained Earnings	-	289.63	252.08	242.48	96.51
Treasury Stock	-	-99.99	-	-	-
Comprehensive Income & Other	-	-8.6	-6.96	-7.25	0.43
Shareholders' Equity	2,002	2,027	2,090	2,076	628.86
Total Liabilities & Equity	-	2,418	2,415	2,359	906.13
Total Debt	236.14	82.2	57.3	40.82	27.78
Net Cash (Debt)	913.03	1,099	1,217	1,469	165.68
Net Cash Growth	-16.90%	-9.72%	-17.17%	786.71%	40.92%
Net Cash Per Share	10.50	12.35	13.44	19.93	2.47
Filing Date Shares Outstanding	85.7	88.33	90.88	90.88	68.16
Total Common Shares Outstanding	86.15	88.33	90.88	90.88	68.16
Working Capital	-	1,863	1,986	1,996	568.15
Book Value Per Share	23.24	22.95	22.99	22.84	9.23
Tangible Book Value	1,999	2,023	2,089	2,076	628.42
Tangible Book Value Per Share	23.20	22.91	22.98	22.84	9.22
Buildings	-	85.07	16.58	16.58	16.58
Machinery	-	45.93	47.23	35.62	21.9
Construction In Progress	-	15.41	-	5.1	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.